Header Logo

Cynthia Comella

Concepts (439)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Torticollis
45
2023
69
10.520
Why?
Parkinson Disease
73
2023
1164
5.420
Why?
Botulinum Toxins, Type A
24
2023
34
5.260
Why?
Dystonia
21
2023
53
3.800
Why?
Botulinum Toxins
20
2018
32
3.630
Why?
Dystonic Disorders
18
2023
29
3.350
Why?
Neuromuscular Agents
13
2023
19
3.070
Why?
Sleep Wake Disorders
9
2014
148
1.960
Why?
Humans
166
2023
29364
1.780
Why?
Restless Legs Syndrome
8
2015
11
1.770
Why?
Severity of Illness Index
28
2019
1113
1.740
Why?
Dopamine Agonists
8
2021
46
1.640
Why?
Antiparkinson Agents
12
2021
130
1.620
Why?
Middle Aged
87
2021
9824
1.380
Why?
Exercise Therapy
8
2018
112
1.330
Why?
Tardive Dyskinesia
4
2020
4
1.210
Why?
Female
93
2023
16214
1.210
Why?
Male
94
2023
15640
1.190
Why?
Levodopa
9
2021
142
1.070
Why?
Antipsychotic Agents
4
2020
82
1.040
Why?
Acetylcholine Release Inhibitors
4
2018
4
1.030
Why?
Tetrabenazine
3
2019
3
1.020
Why?
Valine
3
2019
11
1.020
Why?
Patient Satisfaction
3
2019
295
0.980
Why?
Aged
65
2020
9448
0.970
Why?
Blepharospasm
7
2022
8
0.960
Why?
Adult
59
2023
8606
0.940
Why?
Muscle Weakness
6
2016
32
0.890
Why?
Apomorphine
2
2021
37
0.870
Why?
Tremor
10
2023
141
0.860
Why?
Carbidopa
4
2021
45
0.860
Why?
Neurologic Examination
7
2016
146
0.840
Why?
Vesicular Monoamine Transport Proteins
2
2019
4
0.840
Why?
Treatment Outcome
24
2023
3476
0.820
Why?
Dopamine Agents
3
2015
40
0.810
Why?
Anti-Dyskinesia Agents
4
2013
6
0.810
Why?
Movement Disorders
6
2023
141
0.810
Why?
Double-Blind Method
21
2021
504
0.770
Why?
Neck
4
2023
33
0.770
Why?
Ubiquitin-Protein Ligases
8
2014
36
0.750
Why?
Muscle Rigidity
2
2018
26
0.720
Why?
Multiple System Atrophy
5
2022
42
0.710
Why?
Dopamine Antagonists
2
2019
14
0.710
Why?
Dyskinesia, Drug-Induced
2
2019
54
0.700
Why?
Nervous System Diseases
3
2015
145
0.690
Why?
Adrenergic Uptake Inhibitors
1
2019
8
0.680
Why?
Quality of Life
11
2021
664
0.650
Why?
Catatonia
1
2018
1
0.650
Why?
Encephalomyelitis
1
2018
1
0.650
Why?
Parkinsonian Disorders
5
2022
217
0.650
Why?
Myoclonus
1
2018
29
0.650
Why?
Masticatory Muscles
1
2018
1
0.640
Why?
Motor Activity
3
2015
369
0.620
Why?
Disorders of Excessive Somnolence
5
2021
15
0.610
Why?
Head
3
2020
24
0.610
Why?
Supranuclear Palsy, Progressive
4
2022
44
0.610
Why?
Telemedicine
1
2019
99
0.600
Why?
Minimal Clinically Important Difference
1
2018
106
0.570
Why?
Sleep
5
2019
313
0.520
Why?
Anticonvulsants
2
2014
109
0.500
Why?
Neck Muscles
3
2005
13
0.500
Why?
Reproducibility of Results
9
2019
788
0.480
Why?
Health Knowledge, Attitudes, Practice
2
2018
194
0.470
Why?
Genetic Predisposition to Disease
6
2018
441
0.460
Why?
Electromyography
11
2016
78
0.450
Why?
Movement
9
2019
143
0.450
Why?
Randomized Controlled Trials as Topic
4
2016
340
0.380
Why?
Mutation
7
2016
383
0.370
Why?
Video Recording
6
2022
47
0.350
Why?
Machine Learning
2
2019
54
0.340
Why?
Drug Combinations
2
2021
83
0.330
Why?
Basal Ganglia
4
2014
29
0.330
Why?
Sleep Stages
2
2006
34
0.330
Why?
Prospective Studies
13
2023
1813
0.320
Why?
Registries
5
2017
189
0.320
Why?
Muscle Contraction
6
2008
83
0.320
Why?
Age of Onset
9
2018
108
0.310
Why?
Deglutition Disorders
4
2014
45
0.300
Why?
Essential Tremor
4
2013
15
0.300
Why?
Cognition Disorders
7
2015
1010
0.300
Why?
Pergolide
2
2005
14
0.290
Why?
Resistance Training
3
2017
8
0.290
Why?
Diffusion Magnetic Resonance Imaging
3
2019
96
0.290
Why?
Muscle, Skeletal
6
2008
349
0.280
Why?
Brain
6
2019
1687
0.270
Why?
Telephone
1
2006
27
0.270
Why?
Time Factors
10
2015
1620
0.270
Why?
Hallucinations
4
2007
87
0.260
Why?
United States
9
2019
2332
0.260
Why?
Catechol O-Methyltransferase Inhibitors
1
2005
5
0.260
Why?
Muscle Spasticity
3
2016
16
0.260
Why?
Psychotic Disorders
3
2019
43
0.250
Why?
Sleep, REM
3
2003
18
0.250
Why?
Hand Strength
4
2013
59
0.250
Why?
Physical Examination
2
2023
117
0.250
Why?
Cross-Sectional Studies
9
2022
965
0.240
Why?
Drug Administration Schedule
5
2014
223
0.240
Why?
History, 20th Century
2
2017
84
0.240
Why?
Dyskinesias
4
2008
35
0.240
Why?
Clinical Trials as Topic
7
2014
324
0.240
Why?
Follow-Up Studies
12
2016
1829
0.230
Why?
Cerebral Palsy
1
2023
9
0.220
Why?
Autistic Disorder
1
2023
45
0.220
Why?
Neurotoxins
2
2016
19
0.220
Why?
Young Adult
6
2023
1935
0.220
Why?
Psychomotor Performance
5
2014
216
0.220
Why?
Dose-Response Relationship, Drug
7
2014
440
0.220
Why?
Sensitivity and Specificity
3
2021
553
0.220
Why?
Phenotype
5
2021
357
0.210
Why?
Heterozygote
6
2014
103
0.210
Why?
Exercise
2
2017
468
0.210
Why?
Animals
8
2016
4580
0.210
Why?
Injections, Intramuscular
3
2017
11
0.210
Why?
Surveys and Questionnaires
8
2018
1184
0.210
Why?
Benzothiazoles
2
2013
20
0.210
Why?
Feasibility Studies
2
2020
227
0.210
Why?
Videotape Recording
2
2003
43
0.210
Why?
Automobile Driving
1
2002
12
0.210
Why?
Magnetic Resonance Imaging
6
2014
1220
0.210
Why?
Phenylalanine
1
2021
6
0.200
Why?
Drug Administration Routes
1
2021
12
0.200
Why?
Symptom Assessment
1
2021
21
0.200
Why?
Carbamates
1
2021
12
0.200
Why?
Iron
2
2015
22
0.200
Why?
Polysomnography
3
2010
92
0.200
Why?
Glucosylceramidase
2
2012
26
0.200
Why?
Pantothenate Kinase-Associated Neurodegeneration
1
2020
3
0.190
Why?
Martial Arts
1
2020
5
0.190
Why?
Retrospective Studies
8
2022
3273
0.190
Why?
Neuropsychological Tests
8
2015
1251
0.190
Why?
Internationality
1
2020
24
0.190
Why?
Adolescent
5
2023
2280
0.190
Why?
Gait Disorders, Neurologic
2
2017
144
0.190
Why?
Diagnosis, Differential
3
2018
389
0.190
Why?
Image Processing, Computer-Assisted
2
2019
219
0.180
Why?
Longitudinal Studies
6
2018
1442
0.180
Why?
Delayed Diagnosis
1
2019
12
0.180
Why?
Neurites
1
2019
12
0.180
Why?
Analysis of Variance
9
2013
321
0.180
Why?
Mood Disorders
1
2019
31
0.180
Why?
Schizophrenia
1
2019
78
0.170
Why?
Deep Brain Stimulation
2
2011
74
0.170
Why?
Personal Satisfaction
1
2019
47
0.170
Why?
Cerebellum
3
2014
57
0.170
Why?
Central Nervous System Depressants
1
2018
24
0.160
Why?
Autoimmune Diseases of the Nervous System
1
2018
1
0.160
Why?
Glutamate Decarboxylase
1
2018
4
0.160
Why?
Isometric Contraction
5
2006
15
0.160
Why?
Wounds and Injuries
1
1998
44
0.160
Why?
Syndrome
1
2018
82
0.160
Why?
Disease Management
1
2019
114
0.160
Why?
High-Intensity Interval Training
1
2018
2
0.160
Why?
Ataxia
1
2019
79
0.160
Why?
Biomechanical Phenomena
7
2023
669
0.160
Why?
Violence
1
1998
39
0.160
Why?
Aged, 80 and over
11
2020
4851
0.160
Why?
Activities of Daily Living
3
2020
502
0.160
Why?
Age Factors
5
2019
845
0.160
Why?
Hypokinesia
2
2016
27
0.160
Why?
DNA Mutational Analysis
3
2012
56
0.150
Why?
Biomarkers
2
2019
692
0.150
Why?
Autoantibodies
1
2018
100
0.150
Why?
Postural Balance
3
2015
121
0.150
Why?
Intellectual Disability
1
2018
48
0.150
Why?
History, 21st Century
1
2017
36
0.150
Why?
Fatigue
2
2008
59
0.150
Why?
Task Performance and Analysis
1
1997
55
0.150
Why?
Pain
3
2021
391
0.150
Why?
Ethanol
1
2018
134
0.150
Why?
Patient Selection
1
2018
232
0.150
Why?
REM Sleep Behavior Disorder
2
2007
5
0.150
Why?
Exercise Test
1
2018
122
0.150
Why?
Substance-Related Disorders
1
2018
104
0.150
Why?
Posture
3
2022
78
0.150
Why?
Neck Pain
1
2017
32
0.140
Why?
Sleep Apnea Syndromes
2
2007
33
0.140
Why?
Genotype
6
2014
405
0.140
Why?
Drug Compounding
1
2016
3
0.140
Why?
Multicenter Studies as Topic
2
2015
75
0.140
Why?
Muscle Strength
2
2016
127
0.140
Why?
Databases, Factual
2
2015
330
0.140
Why?
Anxiety
3
2023
152
0.140
Why?
Headache
1
2016
43
0.140
Why?
Naloxone
1
2015
12
0.140
Why?
Metabolic Syndrome
1
2016
66
0.130
Why?
Trinucleotide Repeat Expansion
1
2016
47
0.130
Why?
Oxycodone
1
2015
6
0.130
Why?
Diet Therapy
1
2015
9
0.130
Why?
Neuroprotective Agents
2
2009
59
0.130
Why?
Genetic Association Studies
1
2016
86
0.130
Why?
Single-Blind Method
4
2016
118
0.130
Why?
Huntington Disease
1
2016
60
0.130
Why?
Computer Security
1
2015
8
0.130
Why?
Physical Endurance
1
2015
12
0.130
Why?
Europe
1
2015
81
0.130
Why?
Obsessive-Compulsive Disorder
1
2014
23
0.130
Why?
Genetic Testing
5
2014
64
0.130
Why?
Sensorimotor Cortex
1
2014
1
0.130
Why?
Synaptic Transmission
1
2014
46
0.120
Why?
Case-Control Studies
5
2021
638
0.120
Why?
Cohort Studies
5
2020
1939
0.120
Why?
ROC Curve
3
2013
138
0.120
Why?
Depression
3
2018
466
0.120
Why?
Subthalamic Nucleus
1
2014
32
0.120
Why?
Motor Skills Disorders
2
2014
18
0.120
Why?
Health Planning Guidelines
1
2013
11
0.120
Why?
Physical Therapy Modalities
1
1994
80
0.120
Why?
Globus Pallidus
2
2013
31
0.110
Why?
Psychometrics
3
2013
262
0.110
Why?
Observer Variation
3
2005
118
0.110
Why?
Muscle Stretching Exercises
1
2012
4
0.110
Why?
Biomedical Research
1
2013
81
0.110
Why?
Tai Ji
1
2012
10
0.110
Why?
Genetic Carrier Screening
1
2012
12
0.110
Why?
Research Design
1
2014
212
0.110
Why?
Hand
3
2008
45
0.100
Why?
Mandibular Diseases
1
2011
1
0.100
Why?
Smell
1
2010
18
0.100
Why?
Circadian Rhythm
2
2005
281
0.100
Why?
Genetic Counseling
1
2010
5
0.100
Why?
Sex Factors
2
2019
496
0.100
Why?
Azabicyclo Compounds
1
2010
4
0.100
Why?
Touch
2
2021
11
0.090
Why?
Pain Measurement
6
2014
464
0.090
Why?
Pilot Projects
2
2023
394
0.090
Why?
Preoperative Care
1
2011
135
0.090
Why?
Xerostomia
2
2011
7
0.090
Why?
Anisotropy
3
2019
58
0.090
Why?
Hypnotics and Sedatives
1
2010
20
0.090
Why?
Point Mutation
1
2010
30
0.090
Why?
Drug Delivery Systems
1
2010
37
0.090
Why?
Sleep Initiation and Maintenance Disorders
1
2010
58
0.090
Why?
Austria
2
2019
5
0.090
Why?
Germany
2
2019
11
0.090
Why?
Piperazines
1
2010
90
0.090
Why?
Drug Resistance
2
2006
55
0.080
Why?
Antibodies, Bacterial
1
2008
22
0.080
Why?
Spasm
2
2022
7
0.080
Why?
Nerve Degeneration
1
2009
55
0.080
Why?
Neuromuscular Blocking Agents
1
2008
4
0.080
Why?
Nausea
2
2005
27
0.080
Why?
Psychomotor Agitation
2
2020
14
0.080
Why?
Treatment Failure
2
2006
159
0.080
Why?
Nocturnal Myoclonus Syndrome
1
2007
7
0.080
Why?
Substantia Nigra
1
2009
148
0.080
Why?
Disability Evaluation
5
2011
327
0.070
Why?
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
3
2012
10
0.070
Why?
Risk
2
2010
217
0.070
Why?
Sleep Deprivation
1
2007
62
0.070
Why?
Drug Therapy, Combination
2
2005
241
0.070
Why?
Recurrence
1
2007
350
0.070
Why?
Mental Disorders
1
2008
140
0.070
Why?
Wrist
1
2006
17
0.070
Why?
Time
1
2005
18
0.070
Why?
Somatoform Disorders
1
2005
20
0.070
Why?
Interviews as Topic
1
2006
130
0.070
Why?
Gait
2
2023
404
0.070
Why?
Constipation
1
2005
21
0.070
Why?
Drug Synergism
1
2005
64
0.070
Why?
Dizziness
1
2005
20
0.060
Why?
Neurodegenerative Diseases
1
2007
117
0.060
Why?
Catechols
1
2005
1
0.060
Why?
Nitrophenols
1
2005
4
0.060
Why?
Ergolines
1
2005
14
0.060
Why?
Nitriles
1
2005
13
0.060
Why?
Placebos
1
2005
77
0.060
Why?
Benzophenones
1
2005
27
0.060
Why?
Odds Ratio
2
2019
285
0.060
Why?
Family
1
2006
88
0.060
Why?
Logistic Models
2
2019
407
0.060
Why?
Mass Screening
1
2006
177
0.060
Why?
Reference Values
4
2008
227
0.060
Why?
Sickness Impact Profile
3
2008
19
0.060
Why?
Primary Health Care
1
2005
95
0.060
Why?
Mental Status Schedule
2
2015
113
0.060
Why?
Social Skills
1
2023
15
0.060
Why?
Disease Progression
3
2014
788
0.060
Why?
Statistics, Nonparametric
2
2015
138
0.060
Why?
Algorithms
1
2006
400
0.060
Why?
International Classification of Diseases
1
2023
23
0.060
Why?
Employment
1
2023
42
0.060
Why?
Postoperative Complications
2
2009
957
0.060
Why?
Cognitive Dysfunction
1
2012
938
0.060
Why?
Reaction Time
1
2003
123
0.060
Why?
Cluster Analysis
1
2022
52
0.050
Why?
Nerve Growth Factors
1
2003
44
0.050
Why?
Consensus
1
2023
104
0.050
Why?
Water
1
2022
34
0.050
Why?
Prevalence
2
2018
491
0.050
Why?
Caregivers
2
2008
143
0.050
Why?
Computers
1
2022
26
0.050
Why?
Blinking
1
2021
3
0.050
Why?
Bayes Theorem
1
2021
39
0.050
Why?
Acetamides
1
2001
7
0.050
Why?
Pantothenic Acid
1
2020
1
0.050
Why?
Menstrual Cycle
1
2000
27
0.050
Why?
Family Health
2
2010
37
0.050
Why?
Gene Frequency
2
2010
75
0.050
Why?
Tomography, Emission-Computed, Single-Photon
2
2013
75
0.050
Why?
Olfaction Disorders
2
2012
53
0.050
Why?
Regression Analysis
2
2010
298
0.040
Why?
Adrenal Medulla
2
1990
31
0.040
Why?
Risk Factors
3
2011
2446
0.040
Why?
Monoamine Oxidase Inhibitors
2
2009
22
0.040
Why?
Research Subjects
1
2018
13
0.040
Why?
Sample Size
1
2018
25
0.040
Why?
Neurosurgery
2
1990
49
0.040
Why?
Child
1
2023
1345
0.040
Why?
Back
1
1998
3
0.040
Why?
Head Movements
1
1998
7
0.040
Why?
Brain Mapping
2
2010
195
0.040
Why?
Muscle Relaxants, Central
1
1997
5
0.040
Why?
Baclofen
1
1997
15
0.040
Why?
Patient Acceptance of Health Care
1
2018
79
0.040
Why?
Self Report
1
2018
218
0.040
Why?
Diabetes Insipidus
1
1977
3
0.040
Why?
Vasopressins
1
1977
6
0.040
Why?
Cat Diseases
1
1977
5
0.040
Why?
Incidence
1
2019
756
0.040
Why?
Psychiatric Status Rating Scales
1
2018
343
0.040
Why?
Wrist Joint
2
2008
61
0.040
Why?
Teaching
1
1997
62
0.040
Why?
Accelerometry
1
2017
87
0.040
Why?
Motor Skills
2
2009
61
0.040
Why?
Comorbidity
1
2018
497
0.040
Why?
Arm
2
2008
78
0.030
Why?
Muscle Relaxation
2
2006
5
0.030
Why?
Elbow Joint
2
2008
131
0.030
Why?
Accidental Falls
1
2017
116
0.030
Why?
Neurophysiology
1
2015
3
0.030
Why?
Cardiovascular Physiological Phenomena
1
2015
6
0.030
Why?
Databases, Bibliographic
1
2015
11
0.030
Why?
Observational Studies as Topic
1
2014
17
0.030
Why?
Functional Neuroimaging
1
2014
9
0.030
Why?
Cerebrum
1
2014
9
0.030
Why?
Akathisia, Drug-Induced
1
1994
4
0.030
Why?
Alzheimer Disease
1
2006
1943
0.030
Why?
Respiration
1
2015
35
0.030
Why?
Atrophy
1
2014
102
0.030
Why?
Observation
1
2014
16
0.030
Why?
Patient Compliance
2
2009
164
0.030
Why?
Bromocriptine
1
1993
15
0.030
Why?
Chi-Square Distribution
1
2014
145
0.030
Why?
Internet
1
2015
91
0.030
Why?
Linear Models
1
2014
254
0.030
Why?
Muscles
1
1993
72
0.030
Why?
Dementia
2
2012
521
0.030
Why?
Extremities
1
2012
31
0.030
Why?
Diffusion Tensor Imaging
1
2013
81
0.030
Why?
Functional Laterality
1
2013
91
0.030
Why?
beta-Glucosidase
1
2012
1
0.030
Why?
Basal Ganglia Diseases
1
2012
11
0.030
Why?
Fluoroscopy
1
1992
52
0.030
Why?
Injections
1
1992
56
0.030
Why?
Multiplex Polymerase Chain Reaction
1
2011
4
0.030
Why?
Blepharoptosis
1
2011
2
0.030
Why?
Prefrontal Cortex
1
2013
152
0.020
Why?
Canada
1
2011
56
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2011
130
0.020
Why?
Parasympatholytics
1
1990
14
0.020
Why?
Neuromuscular Diseases
1
1990
9
0.020
Why?
Jews
1
2010
4
0.020
Why?
Depressive Disorder
1
2012
187
0.020
Why?
Eszopiclone
1
2010
4
0.020
Why?
Visual Perception
1
2010
50
0.020
Why?
Memory Disorders
1
2012
174
0.020
Why?
Thalamus
1
2010
28
0.020
Why?
Chromatography, High Pressure Liquid
1
2010
36
0.020
Why?
Oxygen
1
2010
85
0.020
Why?
Electrocardiography
1
2011
209
0.020
Why?
Executive Function
1
2010
121
0.020
Why?
Attention
1
2010
143
0.020
Why?
Genetic Variation
1
2009
105
0.020
Why?
Corpus Striatum
1
1990
111
0.020
Why?
Dysarthria
1
2009
5
0.020
Why?
Dominance, Cerebral
1
2009
23
0.020
Why?
Autonomic Nervous System Diseases
1
2009
27
0.020
Why?
Disruptive, Impulse Control, and Conduct Disorders
1
2009
10
0.020
Why?
Diffusion
1
2009
28
0.020
Why?
Microelectrodes
1
2009
36
0.020
Why?
Early Diagnosis
1
2009
65
0.020
Why?
Memory
1
2010
318
0.020
Why?
Biological Assay
1
2008
9
0.020
Why?
Neutralization Tests
1
2008
10
0.020
Why?
Antibody Specificity
1
2008
50
0.020
Why?
Life Expectancy
1
2008
19
0.020
Why?
Managed Care Programs
1
2008
12
0.020
Why?
Dopamine
1
2009
156
0.020
Why?
Cost of Illness
1
2008
54
0.020
Why?
Health Care Costs
1
2008
70
0.020
Why?
Action Potentials
1
2008
137
0.020
Why?
Predictive Value of Tests
1
2009
521
0.020
Why?
Evidence-Based Medicine
1
2008
206
0.020
Why?
Handwriting
1
2006
2
0.020
Why?
Motor Cortex
1
2006
17
0.020
Why?
Data Interpretation, Statistical
1
2006
96
0.020
Why?
Torque
1
2006
27
0.020
Why?
Weights and Measures
1
2005
8
0.020
Why?
Neurons
1
2009
374
0.020
Why?
Demography
1
2005
77
0.020
Why?
Drug Evaluation
1
2005
53
0.020
Why?
Antibody Formation
1
2005
40
0.020
Why?
Acoustic Stimulation
1
2005
47
0.020
Why?
Cues
1
2005
61
0.020
Why?
Cognition
1
2013
1279
0.020
Why?
Cerebral Cortex
1
2006
195
0.010
Why?
Mice
1
2008
1620
0.010
Why?
Clozapine
1
2003
10
0.010
Why?
Nursing Homes
1
2003
38
0.010
Why?
Anorexia
1
2003
4
0.010
Why?
Paresthesia
1
2003
6
0.010
Why?
Injections, Intraventricular
1
2003
13
0.010
Why?
Primidone
1
2003
1
0.010
Why?
Adrenergic Agonists
1
2003
5
0.010
Why?
Vomiting
1
2003
18
0.010
Why?
Hyponatremia
1
2003
10
0.010
Why?
Glial Cell Line-Derived Neurotrophic Factor
1
2003
30
0.010
Why?
Diarrhea
1
2003
48
0.010
Why?
Electric Stimulation Therapy
1
2003
44
0.010
Why?
Weight Loss
1
2003
98
0.010
Why?
Elbow
1
2001
42
0.010
Why?
Receptors, Glutamate
1
2001
5
0.010
Why?
Progesterone
1
2000
26
0.010
Why?
Estrogens
1
2000
33
0.010
Why?
Retreatment
1
1999
11
0.010
Why?
Risk Assessment
1
2003
678
0.010
Why?
Survival Analysis
1
1999
298
0.010
Why?
Motor Neurons
1
1998
21
0.010
Why?
Signal Processing, Computer-Assisted
1
1998
38
0.010
Why?
Infusion Pumps, Implantable
1
1997
13
0.010
Why?
Catheters, Indwelling
1
1997
25
0.010
Why?
Chlorpropamide
1
1977
1
0.010
Why?
Thirst
1
1977
2
0.010
Why?
Polyuria
1
1977
2
0.010
Why?
Pituitary Gland
1
1977
8
0.010
Why?
Cats
1
1977
77
0.010
Why?
Dogs
1
1977
254
0.010
Why?
Transplantation, Autologous
1
1990
195
0.010
Why?
Cervical Vertebrae
1
1993
349
0.010
Why?
Comella's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (439)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_